Cargando…

Targeting CD56 with an antibody–drug conjugate in Merkel cell carcinoma

Linked Article: Esnault et al. Br J Dermatol 2022; 186:295–306.

Detalles Bibliográficos
Autores principales:	Leiendecker, L., Jung, P.S., Obenauf, A.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298988/ https://www.ncbi.nlm.nih.gov/pubmed/34817859 http://dx.doi.org/10.1111/bjd.20894

Ejemplares similares

LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma
por: Leiendecker, Lukas, et al.
Publicado: (2020)

Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
por: Minutilli, Ettore, et al.
Publicado: (2016)

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
por: Shah, Manisha H., et al.
Publicado: (2016)

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
por: Carter, Joseph J., et al.
Publicado: (2009)

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models
por: Yu, Lin, et al.
Publicado: (2017)

Utilizing panels of patient derived xenografts to aid the development of antibody drug conjugates
por: Collins, Scott David, et al.
Publicado: (2017)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
por: Pietropaolo, Valeria, et al.
Publicado: (2020)

Merkel Cell Carcinoma: Epidemiology, Target, and Therapy
por: Hughes, Mathew P., et al.
Publicado: (2014)

Merkel cell carcinoma
por: Mistry, K., et al.
Publicado: (2021)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Merkel cell polyomavirus and associated Merkel cell carcinoma
por: Yang, June F., et al.
Publicado: (2021)

Targeting the epigenetic addiction of Merkel cell carcinoma
por: Mauri, Federico, et al.
Publicado: (2020)

Merkel Cell Polyomavirus Is Frequently Detected in Korean Patients with Merkel Cell Carcinoma
por: Chun, Seung Min, et al.
Publicado: (2013)

Merkel cell carcinoma
por: Koljonen, Virve
Publicado: (2006)

Merkel Cell Carcinoma
por: Dellambra, Elena, et al.
Publicado: (2021)

RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
por: Hesbacher, Sonja, et al.
Publicado: (2016)

CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110
por: Domínguez, Juan Manuel, et al.
Publicado: (2020)

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma
por: Touzé, Antoine, et al.
Publicado: (2009)

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients
por: Paolini, Francesca, et al.
Publicado: (2011)

Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma
por: Lauttia, S, et al.
Publicado: (2014)

Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma
por: Silling, Steffi, et al.
Publicado: (2022)

Antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (Trop-2) and precision treatment of breast cancer
por: Stenvang, Jan, et al.
Publicado: (2022)

Sacituzumab govitecan and other antibody-drug conjugates targeting trophoblast cell-surface antigen 2 (Trop-2) in breast cancer
por: Matusz-Fisher, Ashley, et al.
Publicado: (2022)

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
por: Ryan, M C, et al.
Publicado: (2010)

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma
por: Ramirez‐Fort, M. K., et al.
Publicado: (2020)

Merkel Cell Polyomavirus DNA in Persons without Merkel Cell Carcinoma
por: Wieland, Ulrike, et al.
Publicado: (2009)

From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis
por: Krump, Nathan A., et al.
Publicado: (2021)

Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma
por: Rotondo, John Charles, et al.
Publicado: (2021)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Merkel Cell Carcinoma: New Trends
por: Zwijnenburg, Ellen M., et al.
Publicado: (2021)

The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan—effectiveness, pitfalls and promises
por: Guerra, Emanuela, et al.
Publicado: (2022)

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma
por: von der Grün, Jens, et al.
Publicado: (2019)

HIV diagnoses continue to fall at 56 Dean Street
por: Whitlock, Gary, et al.
Publicado: (2020)

The Role of the Immune Response in Merkel Cell Carcinoma
por: Triozzi, Pierre L., et al.
Publicado: (2013)

Unexpected maspin immunoreactivity in Merkel cell carcinoma
por: Turdean, Sabin Gligore, et al.
Publicado: (2015)

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells
por: Fuh, Franklin K, et al.
Publicado: (2017)

Merkel cell carcinoma of the abdominal wall
por: Gaopande, Vandana L., et al.
Publicado: (2015)

Patterns of Metastasis in Merkel Cell Carcinoma
por: Song, Yun, et al.
Publicado: (2020)

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
por: Smith, L M, et al.
Publicado: (2008)

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
por: Abrahams, Cristina L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dhe50dcvbsekeqrg7lr0h3buk9